Andera Partners is a Paris-based private equity and asset management firm specializing in growth capital, mezzanine financing, infrastructure, and life sciences investments. Founded in 2001, the firm manages approximately €6 billion across more than 360 portfolio companies in Europe and the United States.
43% of their portfolio is in Biotech & Life Sciences. Deal activity increased 140% year-over-year (12 deals in the last 12 months). Average disclosed round size is $103.5M (across 58 rounds with reported amounts).
Portfolio
63
Fund Size
—
Top Stage
Series B
Last 12 Mo
12
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
115 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Cyllene | Series C | — | Jul 2026 |
 Rivermark Medical | Series D | $20M | May 2026 |
 Alveus Therapeutics Inc | Series A | $37M | Feb 2026 |
 Exciva | Series B | — | Jan 2026 |
 TRiCares | Unknown | — | Jan 2026 |
| Alveus Therapeutics Inc | Series A | $160M | Jan 2026 |
 Spiro Medical | Series A | $67M | Jan 2026 |
 TargED Biopharmaceuticals B.V. | Series A | — | Dec 2025 |
 Artios | Series D | $115M | Nov 2025 |
 Adcytherix | Series A | — | Oct 2025 |
 Tubulis | Series C | — | Oct 2025 |
| TTubulis GmbH | Series C | — | Oct 2025 |
 EG 427 | Series B | — | Feb 2025 |
| Exciva | Series B | $59M | Jan 2025 |
 Bioptimus | Series A | $41M | Jan 2025 |
 FIRE1 | Unknown | $120M | Jan 2025 |
 Cyllene Therapeutics | Series B | $28.4M | Jan 2025 |
 Evommune | Series C | $115M | Oct 2024 |
 Inventiva | Unknown | — | Oct 2024 |
 Scirhom | Series A | — | Jul 2024 |
 Grey Wolf Therapeutics | Series B | $50M | May 2024 |
| MMedical Microinstruments | Series C | $110M | Feb 2024 |
| TRiCares | Series D | $50M | Jan 2024 |
 Kestra Medical Technologies | Unknown | $196M | Jan 2024 |
| MMedical Microinstruments | Series C | $110M | Jan 2024 |
Page 1 of 5
Top Co-Investors
EQT Life Sciences27 shared
RA Capital Management21 shared
Kurma Partners17 shared
Sofinnova Partners17 shared
Omega Funds15 shared
Pfizer Ventures13 shared
M Ventures12 shared
Sectoral Asset Management12 shared
Gimv11 shared
The Invus Group, LLC10 shared
Cormorant Asset Management10 shared
Bpifrance9 shared
Pontifax9 shared
Fund+9 shared
High-Tech Gründerfonds9 shared
SV Health Investors9 shared
Wellington Management8 shared
Bayern Kapital8 shared
Arix Bioscience8 shared
Last updated: 7 October 2026